Fayez Sarofim & Co
TMO icon

Fayez Sarofim & Co’s Thermo Fisher Scientific TMO Stock Holding History

Fayez Sarofim & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Sell
3,402
-125
-4% -$60K ﹤0.01% 163
2026
Q1 		$1.73M Buy
3,527
+185
+6% +$100K ﹤0.01% 155
2025
Q4 		$1.94M Sell
3,342
-625
-16% -$353K ﹤0.01% 154
2025
Q3 		$1.92M Sell
3,967
-356
-8% -$166K ﹤0.01% 160
2025
Q2 		$1.75M Sell
4,323
-80
-2% -$33.4K ﹤0.01% 164
2025
Q1 		$2.19M Sell
4,403
-239
-5% -$129K 0.01% 147
2024
Q4 		$2.41M Sell
4,642
-106
-2% -$58.3K 0.01% 148
2024
Q3 		$2.94M Buy
4,748
+1,190
+33% +$704K 0.01% 134
2024
Q2 		$1.97M Buy
3,558
+156
+5% +$89.4K 0.01% 146
2024
Q1 		$1.98M Sell
3,402
-424
-11% -$238K 0.01% 143
2023
Q4 		$2.11M Buy
3,826
+184
+5% +$89.1K 0.01% 137
2023
Q3 		$1.84M Sell
3,642
-105
-3% -$56K 0.01% 145
2023
Q2 		$1.95M Buy
3,747
+66
+2% +$35.6K 0.01% 139
2023
Q1 		$2.12M Sell
3,681
-37
-1% -$20.9K 0.01% 142
2022
Q4 		$2.05M Hold
3,718
– – 0.01% 140
2022
Q3 		$1.89M Buy
3,718
+1,378
+59% +$771K 0.01% 140
2022
Q2 		$1.27M Buy
2,340
+461
+25% +$254K ﹤0.01% 172
2022
Q1 		$1.11M Buy
1,879
+97
+5% +$55.7K ﹤0.01% 188
2021
Q4 		$1.19M Buy
1,782
+223
+14% +$139K ﹤0.01% 195
2021
Q3 		$891K Sell
1,559
-813
-34% -$446K ﹤0.01% 202
2021
Q2 		$1.2M Buy
2,372
+813
+52% +$384K ﹤0.01% 187
2021
Q1 		$711K Buy
1,559
+27
+2% +$12.9K ﹤0.01% 200
2020
Q4 		$714K Buy
1,532
+150
+11% +$70.3K ﹤0.01% 191
2020
Q3 		$610K Hold
1,382
– – ﹤0.01% 184
2020
Q2 		$501K Buy
1,382
+400
+41% +$134K ﹤0.01% 192
2020
Q1 		$278K Buy
+982
New +$310K ﹤0.01% 207

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fayez Sarofim & Co's TMO Position: Q2 2026 in Review

Fayez Sarofim & Co reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q2 2026, selling an estimated $60K and leaving 3,402 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #163.

Fayez Sarofim & Co first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.94M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fayez Sarofim & Co held 3,402 shares of Thermo Fisher Scientific worth $1.71M as of Q2 2026.
  • Fayez Sarofim & Co sold 125 Thermo Fisher Scientific shares in Q2 2026, an estimated $60K.
  • Thermo Fisher Scientific made up ﹤0.01% of Fayez Sarofim & Co's portfolio in Q2 2026, its #163 holding.
  • Fayez Sarofim & Co first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • Fayez Sarofim & Co's Thermo Fisher Scientific position peaked at $2.94M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.